ViAqua Therapeutics Ltd announced that it has received $4,300,000 in a round of funding on June 9, 2021. The transaction included participation from S2G Ventures, Thai Union Group Public Company Limited (SET:TU), Agriline, existing investors VisVires New Protein, a fund managed by VisVires New Protein Capital Pte. Ltd., The Trendlines Group Ltd. (Catalist:42T), Technion Israel Institute Of Technology, Endowment Arm, and Nutreco Investments B.V.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.062 SGD | -4.62% | -7.46% | -31.87% |
03-27 | Trendlines Group Proposes Rights Issue to Raise SG$4.4 Million | MT |
02-22 | Singapore Shares Recover at Market Close After Mid-Day Fall; IFAST's Shares Jump 5% as Profit Balloons 917% in Q4 2023 | MT |
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-31.87% | 45.96M | |
+31.41% | 12.02B | |
+16.56% | 3.09B | |
+4.05% | 1.41B | |
-8.46% | 1.23B | |
+2.39% | 619M | |
+35.03% | 589M | |
-1.12% | 494M | |
+25.93% | 443M | |
+3.90% | 305M |
- Stock Market
- Equities
- 42T Stock
- News The Trendlines Group Ltd.
- ViAqua Therapeutics Ltd announced that it has received $4.3 million in funding from a group of investors